Y0002407

Brivaracetam CRS

European Pharmacopoeia (EP) Reference Standard

• 동의어(들): Brivaracetam, (αS,4R)-α-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide, (2S)-2-[(4R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide, (S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide, UCB 34714, UCB-34714, UCB34714
• 실험식(Hill 표기법): C₁₁H₂₀N₂O₂
• CAS Number: 357336-20-0
• Molecular Weight: 212.29
• MDL number: MFCD25976668
• UNSPSC 코드: 41116107
• UNSPSC 코드: 12352200
• NACRES: NA.24

속성

• Grade: pharmaceutical primary standard
• 제조업체/상표: EDQM
• 응용 분야: pharmaceutical
• 저장 온도: 2-8°C

설명

일반 설명

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. Compendial materials should be used for the purpose described in the appropriate monograph unless otherwise authorized by the National Competent Authority. For further information and support please go to the website of the issuing Pharmacopoeia.

애플리케이션

e.g. pharmaceutical (small molecule)

생화학적/생리학적 작용

Brivaracetam shows approximately 10 times greater potency than levetiracetam (Keppra)*; pIC50 at LBS = 7.0; inhibits audiogenic seizures in seizure-prone mice (ED50 = 14 μmol/kg) and is also effective in other animal models of epilepsy. Brivaracetam is used as an anticonvulsant (antiepileptic) for seizure treatment.

Orally active levetiracetam analog with higher synaptic vesicle protein 2A (SV2A) affinity and >10 times greater in vivo antiseizure efficay.

포장

Unit quantity: 160mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit EDQM reference substance catalogue.

기타 정보

Sales restrictions may apply.

안전성 정보

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable